Claudia Trenkwalder Selected Research

rotigotine

1/2021	Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical Experience.
1/2019	Reply to: A note on rotigotine for restless legs syndrome after renal transplantation.
1/2017	Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study.
5/2016	Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.
1/2016	Significant association between systolic and diastolic blood pressure elevations and periodic limb movements in patients with idiopathic restless legs syndrome.
3/2014	Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study.
1/2014	Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study.
7/2013	Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER.
10/2011	Treatment of restless legs syndrome with rotigotine.
8/2011	Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Trenkwalder Research Topics

Disease

73	Parkinson Disease (Parkinson's Disease) 02/2022 - 09/2002
55	Restless Legs Syndrome (Restless Legs) 10/2021 - 01/2002
19	Dementia (Dementias) 12/2021 - 11/2004
18	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 11/2004
15	Dyskinesias (Dyskinesia) 05/2021 - 01/2005
12	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 11/2004
9	Multiple System Atrophy 01/2022 - 12/2004
8	Cognitive Dysfunction 01/2022 - 01/2006
7	Disease Progression 02/2022 - 10/2014
6	Nausea 01/2019 - 12/2008
5	Movement Disorders (Movement Disorder) 01/2020 - 07/2009
5	Parkinsonian Disorders (Parkinsonism) 01/2019 - 12/2004
5	Pain (Aches) 01/2017 - 04/2005
5	Fatigue 05/2016 - 02/2005
4	Synucleinopathies 01/2022 - 03/2011
4	Dystonia (Limb Dystonia) 01/2022 - 09/2007
4	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2021 - 03/2011
3	Tremor (Tremors) 01/2022 - 12/2011
3	Dizziness (Lightheadedness) 01/2019 - 01/2011
3	Iron Deficiencies 10/2017 - 10/2006
3	Frontotemporal Dementia (Semantic Dementia) 10/2015 - 10/2008
3	Hallucinations (Hallucination) 11/2013 - 09/2005
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 05/2011 - 11/2004
3	Multiple Sclerosis 02/2007 - 06/2002
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Corticobasal Degeneration 12/2021 - 10/2014
2	Diarrhea 01/2019 - 11/2013
2	Hypertension (High Blood Pressure) 01/2019 - 02/2010
2	REM Sleep Behavior Disorder 01/2018 - 08/2003
2	Syncope (Fainting) 09/2017 - 12/2008
2	Teratoma (Teratoid Tumor) 01/2017 - 07/2008
2	Headache (Headaches) 05/2016 - 10/2010
2	Nasopharyngitis 05/2016 - 11/2013
2	Nervous System Diseases (Neurological Disorders) 10/2014 - 03/2011
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2013 - 11/2012
2	Psychotic Disorders (Schizoaffective Disorder) 04/2010 - 02/2007
1	Neuroinflammatory Diseases 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

23	Levodopa (L Dopa)FDA LinkGeneric 05/2021 - 10/2003
22	Biomarkers (Surrogate Marker)IBA 02/2022 - 11/2004
17	Pharmaceutical PreparationsIBA 02/2022 - 02/2007
17	rotigotine FDA Link 01/2021 - 03/2008
15	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 01/2004
13	SynucleinsIBA 01/2022 - 10/2010
10	IronIBA 10/2021 - 09/2002
7	Apomorphine FDA Link 01/2021 - 12/2004
6	alpha-SynucleinIBA 01/2022 - 01/2005
6	Dopamine Agents (Dopaminergic Agents)IBA 01/2018 - 09/2002
5	tau Proteins (tau Protein)IBA 12/2021 - 01/2005
5	Ferritins (Ferritin)IBA 10/2017 - 09/2002
5	Oxycodone (Oxycontin)FDA LinkGeneric 01/2017 - 12/2008
5	Proteins (Proteins, Gene)FDA Link 10/2015 - 10/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2011 - 01/2002
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2011
4	Opioid Analgesics (Opioids)IBA 01/2017 - 04/2005
4	Naloxone (Narcan)FDA LinkGeneric 01/2017 - 12/2013
4	EnzymesIBA 02/2009 - 01/2006
4	Amyloid beta-PeptidesIBA 02/2009 - 05/2006
3	AntibodiesIBA 01/2020 - 10/2014
3	Amantadine (Aman)FDA LinkGeneric 03/2018 - 11/2013
3	Pramipexole (Mirapex)FDA LinkGeneric 01/2018 - 09/2006
3	LigandsIBA 01/2018 - 04/2005
3	mavoglurantIBA 01/2016 - 06/2011
3	Peptides (Polypeptides)IBA 01/2011 - 05/2006
2	Biological ProductsIBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	AutoantibodiesIBA 01/2019 - 10/2014
2	Immunoglobulin A (IgA)IBA 01/2019 - 10/2014
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2014
2	N-Methylaspartate (NMDA)IBA 01/2019 - 10/2014
2	Immunoglobulin M (IgM)IBA 01/2019 - 10/2014
2	ferric carboxymaltoseIBA 01/2018 - 10/2017
2	Transferrin (beta 2 Transferrin)IBA 10/2017 - 09/2002
2	Opioid Receptors (Opioid Receptor)IBA 01/2017 - 04/2005
2	ApolipoproteinsIBA 01/2016 - 01/2006
2	EpitopesIBA 10/2014 - 11/2012
2	Protein Isoforms (Isoforms)IBA 11/2012 - 01/2006
2	ImmunosorbentsIBA 02/2009 - 01/2007
2	Growth Hormone (Somatotropin)IBA 08/2007 - 12/2004
2	Cabergoline FDA LinkGeneric 04/2007 - 10/2003
2	Fatty Acid Binding Protein 3IBA 01/2007 - 11/2004
2	GadoliniumIBA 05/2006 - 06/2002
2	Pergolide (Permax)FDA Link 09/2005 - 01/2002
1	Lipoproteins (Lipoprotein)IBA 02/2022
1	Histone-Lysine N-MethyltransferaseIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	BenzodiazepinesIBA 05/2021
1	COVID-19 VaccinesIBA 01/2021
1	NucleotidesIBA 01/2021

Therapy/Procedure

16	Therapeutics 10/2021 - 09/2006
7	Transdermal Patch 01/2021 - 12/2008
5	Deep Brain Stimulation 01/2022 - 02/2010
3	Kidney Transplantation 01/2019 - 09/2002
3	Transplantation 01/2017 - 01/2004
3	Subcutaneous Injections 01/2017 - 07/2008
2	Contraindications 01/2021 - 12/2017
2	Electrodes (Electrode) 01/2020 - 02/2010
2	Drug Therapy (Chemotherapy) 10/2019 - 12/2017